Items where authors include "de Latour, R.P."

Article

Styczynski, J. orcid.org/0000-0002-3158-119X, Tridello, G., Koster, L. et al. (25 more authors) (2023) Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT. Bone Marrow Transplantation, 58 (8). pp. 881-892. ISSN 0268-3369

Saccardi, R., Putter, H. orcid.org/0000-0001-5395-1422, Eikema, D.-J. et al. (45 more authors) (2023) Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation, 58 (6). pp. 659-666. ISSN 0268-3369

Passweg, J.R., Baldomero, H. orcid.org/0000-0002-6554-483X, Ciceri, F. et al. (12 more authors) (2023) Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT activity survey. Bone Marrow Transplantation, 58 (6). pp. 647-658. ISSN 0268-3369

Yakoub-Agha, I. orcid.org/0000-0003-4524-8782, Greco, R. orcid.org/0000-0002-6117-5328, Onida, F. et al. (14 more authors) (2023) Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplantation, 58 (6). pp. 696-700. ISSN 0268-3369

Snowden, J.A. orcid.org/0000-0001-6819-3476, Sánchez-Ortega, I., Corbacioglu, S. et al. (17 more authors) (2022) Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplantation, 57 (8). pp. 1217-1239. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Basak, G.W. orcid.org/0000-0003-3858-8180 et al. (14 more authors) (2019) The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplantation, 54 (10). pp. 1575-1585. ISSN 0268-3369